Perspective Therapeutics (CATX) Earnings Date & Reports

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CATX is expected to report earnings to rise 17.16% to -29 cents per share on August 08

Perspective Therapeutics CATX Stock Earnings Reports

Q2'25

Est.

$-0.29

Q1'25

Beat

by $0.06

Q4'24

Missed

by $0.30

Q3'24

Est.

$-0.21

Q2'24

Missed

by $0.16

The last earnings report on May 13 showed earnings per share of -25 cents, beating the estimate of -31 cents. With 1.13M shares outstanding, the current market capitalization sits at 751.25M.

View a ticker or compare two or three

Compare

CATX